Noelle LeVeaux
About Noelle LeVeaux
Independent director (age 52) serving on FrontView REIT, Inc.’s board since 2024; Chair of the Compensation Committee and member of the Nominating & Corporate Governance Committee. Background in marketing, communications, and brand strategy; CEO of Noelle LeVeaux Concepts (digital communications and brand development). Education: MS in Digital Communication Analytics (University of North Texas) and BS in Mathematics (Spelman College).
Past Roles
| Organization | Role | Tenure | Committees/Impact |
|---|---|---|---|
| Noelle LeVeaux Concepts | Chief Executive Officer | 2024; 2017–2020 | Marketing strategies and brand development for client growth and communications management. |
| D Magazine Partners | Group Publisher | 2022–2024 | Revenue generation, sales, and marketing for print, online, and events. |
| Communities Foundation of Texas | Chief Marketing Officer | 2020–2022 | Led enterprise marketing. |
| Dallas Convention & Visitors Bureau | Chief Marketing Officer | 2012–2017 | Oversaw branding, campaigns, and tourism promotion. |
| Children’s Medical Center (Dallas) | Senior Director/Vice President, Marketing & PR | Prior to 2012 | Internal communications, clinical marketing, advertising, media, events, digital. |
External Roles
| Organization | Role |
|---|---|
| Dress for Success Dallas | Co-founder (affiliate of international non-profit) |
| Community Partners of Dallas | Board member |
| City Year Dallas | Board chair-elect |
| Uptown Dallas Inc. | Chair, Marketing Committee |
- No current public company directorships disclosed.
Board Governance
- Committee assignments: Chair, Compensation; Member, Nominating & Corporate Governance; Independent status affirmed by Board.
- Board and committee attendance: 100% by all directors in 2024; Board met 2 times; Audit (1), Compensation (1), Nominating (1).
- Non-employee directors meet regularly in executive session.
- Governance highlights: annual director elections; majority independent board; no poison pill; no supermajority vote requirements; shareholders representing a majority can call special meetings.
- Board size increased to eight on Nov 13, 2025 with Maewyn designee Charles Fitzgerald appointed; Maewyn holds ongoing nomination rights subject to ownership threshold.
Fixed Compensation
| Component | Amount | Notes |
|---|---|---|
| Annual Cash Retainer | $50,000 | For non-employee directors. |
| Committee Chair Fees | $10,000 | Compensation Committee chair; Audit Chair $15,000; Nominating Chair $10,000. |
| Meeting Fees | None disclosed | Policy does not list per-meeting fees; expense reimbursement provided. |
2024 actual compensation (partial year post-IPO):
| Metric | 2024 Amount |
|---|---|
| Fees Earned or Paid in Cash ($) | $15,000 |
| Stock Awards ($) | $45,011 (Initial RSU grant at IPO) |
| Total ($) | $60,011 |
Performance Compensation
| Equity Award | Grant Value | Shares/Units | Vesting | Notes |
|---|---|---|---|---|
| Initial RSU Grant (IPO, effective Oct 4, 2024) | $45,000 | 2,369 RSUs | Vests in full on the day before the first annual stockholders’ meeting | Fair value reported $45,011. |
| Annual RSU Grant (each annual meeting) | $90,000 (value at grant) | Shares determined by closing price at grant | Vests on earlier of 1 year or day before next annual meeting (≥50 weeks later) | Unvested non-employee director awards automatically vest upon Change in Control. |
- No director performance metrics (e.g., TSR, EBITDA) tied to director compensation disclosed; RSU awards are time-based.
Other Directorships & Interlocks
- No public company board interlocks or roles disclosed for LeVeaux; Compensation Committee uses an independent consultant (Ferguson Partners Consulting, L.P.).
Expertise & Qualifications
- 30 years of experience in marketing, communications, and advertising, including brand building, campaign planning, and marketing infrastructure; leadership roles across media, healthcare, philanthropy, and tourism.
- Academic credentials: MS Digital Communication Analytics (University of North Texas); BS Mathematics (Spelman College).
Equity Ownership
| Item | Amount |
|---|---|
| Beneficial ownership (shares) | 2,369; less than 1% of outstanding common stock |
| Outstanding RSUs | 2,369 |
| Shares pledged as collateral | None (no pledging by any director/officer) |
| Ownership guidelines (director) | Not disclosed in proxy |
Governance Assessment
- Strengths: Independent director; Chairs Compensation Committee; 100% attendance; majority independent board and regular executive sessions; use of independent compensation consultant; no pledging; clear director equity program with defined vesting; no poison pill or supermajority provisions.
- Comp structure/Alignment: Cash retainer + equity RSUs; time-based vesting aligns with multi-year service; automatic vesting upon Change in Control for non-employee directors is standard but can reduce retention incentives through a transaction.
- Potential conflicts/related-party exposure: None involving LeVeaux disclosed; internalization and OP Unit issuances benefited certain executives/directors (not LeVeaux).
- Risk indicators: Emerging growth company status—no Say-on-Pay votes required yet; requires continued committee rigor and investor engagement.
- New investor influence: Nov 2025 Investor Rights Agreement grants Maewyn nomination rights and certain consent rights (e.g., leverage limits), potentially influencing board dynamics; as Compensation Chair, LeVeaux will need to balance independent oversight with preferred holder governance features.
Committee Assignments
| Committee | Role |
|---|---|
| Compensation | Chair |
| Nominating & Corporate Governance | Member |
RED FLAGS
- Automatic vesting of director RSUs on Change in Control (single-trigger for directors) may be perceived as less shareholder-friendly by some investors.
- Preferred investor board nomination and consent rights could constrain flexibility and introduce governance complexity; monitor committee independence and board processes post-appointment.
Notes on Policies
- Insider Trading Policy adopted; filed as Exhibit 19.1 to 2024 10-K.
- Clawback Policy applies to covered executives for incentive compensation tied to financial reporting; not specified as applying to directors.
- Compensation Committee Interlocks: None; members are independent and not current/former employees.